A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors

References

• Mahlangu J, Oldenburg J, Callaghan MU, et al. Health-related quality of life and health status in persons with haemophilia A with inhibitors: a prospective, multicentre, non-interventional study (NIS). Haemophilia. 2019;25(3):382–391. doi:10.1111/hae.13731
   PubMed Web of Science ®Google Scholar
• Chen SL. Economic costs of hemophilia and the impact of prophylactic treatment on patient management. Am J Manag Care. 2016;22(5 Suppl):s126–s133.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1–e47.
   PubMed Web of Science ®Google Scholar
• Meeks SL, Batsuli G. Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches. Hematology Am Soc Hematol Educ Program. 2016;2016(1):657–662. doi:10.1182/asheducation-2016.1.657
   PubMed Web of Science ®Google Scholar
• Centers of Disease Control & Prevention (CDC). Inhibitors and Hemophilia. Available from: https://www.cdc.gov/ncbddd/hemophilia/inhibitors.html#ref1. Accessed September 29, 2021.
   Google Scholar
• Ayanian JZ, Landrum MB, Normand S-LT, Guadagnoli E, McNeil BJ. Rating the appropriateness of coronary angiography — Do practicing physicians agree with an expert panel and with each other? N Engl J Med. 1998;338(26):1896–1904. doi:10.1056/NEJM199806253382608
   Web of Science ®Google Scholar
• Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ. 2000;321(7258):425. doi:10.1136/bmj.321.7258.425
   PubMed Web of Science ®Google Scholar
• Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force–2. Value Health. 2012;15(6):804–811. doi:10.1016/j.jval.2012.06.016
   PubMed Web of Science ®Google Scholar
• Eubank BH, Mohtadi NG, Lafave MR, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol. 2016;16(1):56. doi:10.1186/s12874-016-0165-8
   PubMed Web of Science ®Google Scholar
• Armstrong C, Grant S, Kinnett K, et al. Participant experiences with a new online modified-Delphi approach for engaging patients and caregivers in developing clinical guidelines. Eur J Pers Cent Healthc. 2019;7(3):476–489.
   Google Scholar
• Santaguida P, Dolovich L, Oliver D, et al. Protocol for a Delphi consensus exercise to identify a core set of criteria for selecting health related outcome measures (HROM) to be used in primary health care. BMC Fam Pract. 2018;19(1):152. doi:10.1186/s12875-018-0831-5
   Web of Science ®Google Scholar
• Santaguida PL, Oliver D, Gilsing A, et al. Delphi consensus on core criteria set selecting among health-related outcome measures (HROM) in primary health care. J Clin Epidemiol. 2020;127:105–116. doi:10.1016/j.jclinepi.2020.04.028
   Web of Science ®Google Scholar
• Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–409. doi:10.1016/j.jclinepi.2013.12.002
   PubMed Web of Science ®Google Scholar
• Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 2011;6(6):e20476. doi:10.1371/journal.pone.0020476
   PubMed Web of Science ®Google Scholar
• Birko S, Dove ES, Ozdemir V. Evaluation of nine consensus indices in Delphi foresight research and their dependency on Delphi survey characteristics: a simulation study and debate on Delphi design and interpretation. PLoS One. 2015;10(8):e0135162. doi:10.1371/journal.pone.0135162
   PubMed Web of Science ®Google Scholar
• National Hemophilia Foundation. MASAC Recommendations. Available from: https://www.hemophilia.org/Researchers-Healthcare-Providers/Medical-and-Scientific-Advisory-Council-MASAC/MASAC-Recommendations. Accessed July 2, 2020.
   Google Scholar
• US Food and Drug Administration. Evaluating inclusion and exclusion criteria in clinical trials. FDA report; 2019.
   Google Scholar
• Wood L, Bjarnason GA, Black PC, et al. Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma. J Oncol Pract. 2013;9(5):e262–e267. doi:10.1200/JOP.2012.000870
   Google Scholar
• Meshkat B, Cowman S, Gethin G, et al. Using an e-Delphi technique in achieving consensus across disciplines for developing best practice in day surgery in Ireland. J Hosp Adm. 2014;3(4):1–8. doi:10.5430/jha.v3n4p1
   Google Scholar
• Colonna P, Andreotti F, Ageno W, Pengo V, Marchionni N. Clinical conundrums in antithrombotic therapy management: a Delphi Consensus panel. Int J Cardiol. 2017;249:249–256. doi:10.1016/j.ijcard.2017.09.159
   Web of Science ®Google Scholar
• World Federation of Hemophilia. Guidelines for the Management of Hemophilia. 2020. doi:10.1111/hae.14046
   Google Scholar
• Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood. 2009;114(26):5256–5263. doi:10.1182/blood-2009-07-215665
   PubMed Web of Science ®Google Scholar
• Coppola A, Tagliaferri A, Franchini M. The management of cardiovascular diseases in patients with hemophilia. Semin Thromb Hemost. 2010;36(1):91–102. doi:10.1055/s-0030-1248728
   Web of Science ®Google Scholar
• Dane KE, Lindsley JP, Streiff MB, Moliterno AR, Khalid MK, Shanbhag S. Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention. Res Pract Thromb Haemost. 2019;3(3):420–423. doi:10.1002/rth2.12201
   PubMed Web of Science ®Google Scholar
• Knoebl P, Sperr W, Schellongowski P, et al. Emicizumab for the treatment of acquired Hemophilia A: lessons learned from 4 very different cases. Hamostaseologie. 2019;39(S 01):SY13-SY15-AB.
   Google Scholar
• Broderick CR, Herbert RD, Latimer J, et al. Association between physical activity and risk of bleeding in children with hemophilia. JAMA. 2012;308(14):1452–1459. doi:10.1001/jama.2012.12727
   PubMed Web of Science ®Google Scholar
• Zanon E, Tagliaferri A, Pasca S, et al. Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study. Blood Transfus. 2020;18(2):152–158.
   Web of Science ®Google Scholar
• Mahlangu J, Oldenburg J, Paz-Priel I, et al. Emicizumab prophylaxis in patients who have Hemophilia A without inhibitors. N Engl J Med. 2018;379(9):811–822. doi:10.1056/NEJMoa1803550
   PubMed Web of Science ®Google Scholar
• National Institute of Health. A clinical trial to evaluate prophylactic emicizumab versus no prophylaxis in Hemophilia A participants without inhibitors (HAVEN 3); 2016. Available from: https://clinicaltrials.gov/ct2/show/NCT02847637. Accessed September 29, 2021.
   Google Scholar
• Roushan N, Meysamie A, Managhchi M, Esmaili J, Dormohammadi T. Bone mineral density in hemophilia patients. Indian J Hematol Blood Transfus. 2014;30(4):351–355. doi:10.1007/s12288-013-0318-4
   PubMed Web of Science ®Google Scholar
• Sahin S, Sadri S, Baslar Z, Ar MC. Osteoporosis in patients with hemophilia: single-center results from a middle-income country. Clin Appl Thromb Hemost. 2019;25:1076029619861689. doi:10.1177/1076029619861689
   Web of Science ®Google Scholar
• Gamal Andrawes N, Hashem Fayek M, Salah El-Din N, Atef Mostafa R. Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A. Haemophilia. 2020;26(2):325–332. doi:10.1111/hae.13917
   Web of Science ®Google Scholar
• Gupta UG, Clarke RE. Theory and applications of the Delphi technique: a bibliography (1975–1994). Technol Forecast Soc Change. 1996;53(2):185–211.
   Web of Science ®Google Scholar
• Fletcher AJ, Marchildon GP. Using the Delphi method for qualitative, participatory action research in health leadership. Int J Qual Methods. 2014;13(1):1–18. doi:10.1177/160940691401300101
   Google Scholar
• Bonnet P, Gringeri A, Gomperts E, et al. Modeling costs and outcomes associated with a treatment algorithm for problem bleeding episodes in patients with severe hemophilia A and high-titer inhibitors. Am Health Drug Benefits. 2011;4(4):219.
   Google Scholar
• Martinoli C, Alberighi OD, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost. 2013;109(06):1170–1179. doi:10.1160/TH12-11-0874
   Web of Science ®Google Scholar
• Neufeld EJ, Solimeno L, Quon D, et al. Perioperative management of haemophilia B: a critical appraisal of the evidence and current practices. Haemophilia. 2017;23(6):821–831. doi:10.1111/hae.13279
   Web of Science ®Google Scholar
• Seuser A, Khayat CD, Negrier C, Sabbour A, Heijnen L. Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus. Blood Coagul Fibrinolysis. 2018;29(6):509. doi:10.1097/MBC.0000000000000767
   Web of Science ®Google Scholar